NeuroSense Therapeutics (NRSN) Stock Chart & Stock Price History → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free NRSN Stock Alerts $1.08 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NeuroSense Therapeutics Stock Price Performance5 Day Performance-0.92%1 Month Performance-14.96%3 Month Performance-47.32%6 Month Performance-16.28%Year-To-Date Performance+37.58%1 Year Performance-42.55% Receive NRSN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NRSN Stock Chart for Sunday, June, 2, 2024 NRSN Chart by TradingView NeuroSense Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.08$1.08$1.13$1.02106,098 shs$14.76 million05/30/2024$1.11$1.08-2.70%$1.14$1.0652,508 shs$14.76 million05/29/2024$1.09$1.11+1.83%$1.18$1.0345,748 shs$15.17 million05/28/2024$1.17$1.09-6.60%$1.21$1.0871,080 shs$14.90 million05/27/2024$1.17$1.17$1.22$1.0638,200 shs$15.95 million05/24/2024$1.16$1.17+0.60%$1.22$1.0638,180 shs$15.95 million Get the Latest News and Ratings for NRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.24$1.16-6.45%$1.27$1.0298,967 shs$15.86 million05/22/2024$1.26$1.24-1.59%$1.30$1.1952,729 shs$16.95 million05/21/2024$1.26$1.26$1.32$1.1469,718 shs$17.22 million05/20/2024$1.21$1.26+4.13%$1.34$1.17194,568 shs$17.22 million05/17/2024$1.20$1.21+0.83%$1.29$1.1679,968 shs$16.67 million05/16/2024$1.20$1.20+0.17%$1.23$1.1730,389 shs$16.40 million05/15/2024$1.12$1.20+6.96%$1.20$1.1461,973 shs$16.38 million05/14/2024$1.15$1.12-2.61%$1.22$1.1155,482 shs$15.31 million05/13/2024$1.18$1.15-2.54%$1.21$1.0662,455 shs$15.72 million05/10/2024$1.17$1.18+0.53%$1.30$1.1595,731 shs$16.13 million05/09/2024$1.23$1.17-4.57%$1.25$1.08121,336 shs$16.04 million05/08/2024$1.29$1.23-4.65%$1.35$1.2181,070 shs$16.81 million05/07/2024$1.27$1.29+1.57%$1.49$1.20406,090 shs$17.63 million05/06/2024$1.33$1.27-4.51%$1.34$1.2357,356 shs$17.36 million05/03/2024$1.27$1.33+4.72%$1.34$1.19136,592 shs$18.18 million05/02/2024$1.26$1.27+0.79%$1.36$1.22104,024 shs$17.36 million05/01/2024$1.35$1.26-6.67%$1.42$1.2445,673 shs$17.22 million04/30/2024$1.29$1.35+4.65%$1.37$1.2613,242 shs$18.45 million04/29/2024$1.23$1.29+4.88%$1.32$1.2314,591 shs$17.63 million04/26/2024$1.26$1.23-2.38%$1.29$1.1742,068 shs$16.81 million04/25/2024$1.34$1.26-5.97%$1.32$1.21139,169 shs$17.22 million04/24/2024$1.36$1.34-1.47%$1.50$1.30132,898 shs$18.32 million04/23/2024$1.35$1.36+0.74%$1.37$1.3079,099 shs$18.59 million04/22/2024$1.42$1.35-4.93%$1.44$1.11355,849 shs$18.45 million04/19/2024$1.52$1.42-6.58%$1.53$1.30121,555 shs$19.41 million04/18/2024$1.60$1.52-5.00%$1.62$1.45267,082 shs$20.77 million04/17/2024$1.65$1.60-3.03%$1.64$1.5672,130 shs$21.87 million04/16/2024$1.53$1.65+7.84%$1.73$1.52115,582 shs$22.56 million04/15/2024$1.60$1.53-4.38%$1.66$1.5272,243 shs$20.92 million04/12/2024$1.68$1.60-4.76%$1.81$1.53159,672 shs$21.87 million04/11/2024$1.66$1.68+1.20%$1.78$1.51277,203 shs$22.97 million04/10/2024$1.72$1.66-3.49%$1.69$1.55148,488 shs$22.69 million04/09/2024$1.74$1.72-1.15%$1.93$1.61177,040 shs$23.51 million04/08/2024$1.70$1.74+2.35%$1.81$1.67163,301 shs$23.79 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/05/2024$2.06$1.70-17.48%$2.25$1.50918,364 shs$23.24 million04/04/2024$2.05$2.06+0.49%$2.25$1.97250,683 shs$28.15 million04/03/2024$1.84$2.05+11.41%$2.13$1.81317,747 shs$28.02 million04/02/2024$1.83$1.84+0.55%$1.84$1.7463,128 shs$25.15 million04/01/2024$1.82$1.83+0.55%$1.86$1.7680,636 shs$25.02 million03/29/2024$1.82$1.82$1.85$1.73113,890 shs$24.87 million03/28/2024$1.73$1.82+5.20%$1.85$1.73113,446 shs$24.88 million03/27/2024$1.70$1.73+1.76%$1.81$1.6982,346 shs$23.65 million03/26/2024$1.82$1.70-6.59%$1.82$1.45133,684 shs$23.24 million03/25/2024$1.76$1.82+3.41%$1.83$1.7355,450 shs$24.88 million03/22/2024$1.81$1.76-2.76%$1.89$1.72184,016 shs$24.06 million03/21/2024$1.67$1.81+8.38%$1.85$1.75210,956 shs$24.74 million03/20/2024$1.48$1.67+12.84%$1.68$1.48157,259 shs$22.83 million03/19/2024$1.41$1.48+5.34%$1.58$1.40309,265 shs$20.23 million03/18/2024$1.38$1.41+1.81%$1.43$1.32195,120 shs$19.21 million03/15/2024$1.39$1.38-0.72%$1.47$1.31117,198 shs$18.87 million03/14/2024$1.64$1.39-15.24%$1.73$1.35256,929 shs$19.00 million03/13/2024$1.57$1.64+4.46%$1.69$1.54158,789 shs$22.42 million03/12/2024$1.67$1.57-5.99%$1.67$1.51195,565 shs$21.46 million03/11/2024$1.79$1.67-6.70%$1.84$1.60205,761 shs$22.83 million03/08/2024$2.01$1.79-10.95%$2.09$1.72468,188 shs$24.47 million03/07/2024$2.08$2.01-3.37%$2.10$1.99145,676 shs$27.48 million03/06/2024$2.03$2.08+2.46%$2.13$1.98307,970 shs$28.43 million03/05/2024$2.11$2.03-3.79%$2.08$1.90375,473 shs$27.74 million03/04/2024$2.05$2.11+2.93%$2.29$1.96478,678 shs$28.84 million03/01/2024$1.77$2.05+15.82%$2.33$1.771.28 million shs$28.02 million Related Companies: CALC Stock Chart LPTX Stock Chart RPHM Stock Chart BLRX Stock Chart CARM Stock Chart RMTI Stock Chart AEON Stock Chart ANEB Stock Chart THAR Stock Chart KZR Stock Chart Receive NRSN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRSN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroSense Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.